治疗高血压的脏缩:临床最先进的技术审查
Andrew S P Sharp1,2, Naomi D L Fisher3,4
1School of Medicine, University College Dublin, Dublin, Ireland.
American journal of hypertension
|July 24, 2025
概括
脏缩 (RDN) 是一种治疗高血压的新方法. 最近的试验表明,RDN在许多患者中有效降低血压,特别是那些有抗性高血压的人.
科学领域:
- 心血管医学 心血管医学
- 干预心脏病学 干预心脏病学
- 腎臟病學 (nephrology) 是一種醫學.
背景情况:
- 高血压是全球主要的健康风险,尽管有治疗方法,但控制率不佳.
- 脏缩 (RDN) 为管理难以控制的高血压提供了一种程序选择.
- 最近的FDA批准强调了越来越多的RDN安全性和有效性的证据.
研究的目的:
- 审查当前的证据和指导方针,以脏缩作为高血压的辅助疗法.
- 讨论患者选择,手术技巧和RDN的预期结果.
- 强调多学科方法在使用RDN治疗耐药高血压方面的重要性.
主要方法:
- 分析第二代随机化,模拟控制的临床试验,评估RDN.
- 从射频 (Spyral) 和超声波 (Paradise) 废除导管的数据的审查.
- 检查患者的特征,包括药物使用和血压的基线.
主要成果:
- 在患有轻度至中度和抗性高血压的患者中,RDN显示显著降低血压.
- 在服用和停用抗高血压药物的患者中观察到有效性.
- 基线压缩性血压是治疗反应的关键预测指标.
结论:
- 脏缩是高血压的安全有效的辅助疗法,特别是耐药病例.
- 在考虑RDN之前,共享决策和医疗疗法的优化至关重要.
- 建议高血压专家和干预专家之间采取协作方法,以实现最佳的患者管理.
相关概念视频
Antihypertensive Drugs: Direct Renin Inhibitors
827
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
827
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
510
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
510
Antihypertensive Drugs: Action of Diuretics
874
Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various...
874
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
888
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
888
Antihypertensive Drugs: Action of β1 Blockers
612
β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this,...
612
Hypertension II: Pathophysiology
79
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
79


